nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentamidine—CYP1A1—head and neck cancer	0.603	1	CbGaD
Pentamidine—CYP2D6—Hydroxyurea—head and neck cancer	0.0651	0.303	CbGbCtD
Pentamidine—CYP2C8—Fluorouracil—head and neck cancer	0.039	0.181	CbGbCtD
Pentamidine—CYP3A5—Docetaxel—head and neck cancer	0.031	0.144	CbGbCtD
Pentamidine—CYP1A2—Fluorouracil—head and neck cancer	0.0302	0.14	CbGbCtD
Pentamidine—CYP2D6—Vinblastine—head and neck cancer	0.023	0.107	CbGbCtD
Pentamidine—CYP3A4—Vinblastine—head and neck cancer	0.0146	0.0681	CbGbCtD
Pentamidine—CYP3A4—Docetaxel—head and neck cancer	0.0121	0.0562	CbGbCtD
Pentamidine—Electrocardiogram ST segment—Fluorouracil—head and neck cancer	0.0093	0.0811	CcSEcCtD
Pentamidine—Abortion spontaneous—Fluorouracil—head and neck cancer	0.00648	0.0565	CcSEcCtD
Pentamidine—Memory loss—Fluorouracil—head and neck cancer	0.00298	0.026	CcSEcCtD
Pentamidine—Inappropriate antidiuretic hormone secretion—Vinblastine—head and neck cancer	0.0023	0.0201	CcSEcCtD
Pentamidine—Blepharitis—Hydroxyurea—head and neck cancer	0.00198	0.0173	CcSEcCtD
Pentamidine—Hypomagnesaemia—Hydroxyurea—head and neck cancer	0.00192	0.0167	CcSEcCtD
Pentamidine—Local reaction—Fluorouracil—head and neck cancer	0.00158	0.0138	CcSEcCtD
Pentamidine—Extravasation—Vinblastine—head and neck cancer	0.00153	0.0134	CcSEcCtD
Pentamidine—Blepharitis—Fluorouracil—head and neck cancer	0.00142	0.0124	CcSEcCtD
Pentamidine—Raised liver function tests—Docetaxel—head and neck cancer	0.00137	0.012	CcSEcCtD
Pentamidine—Chest tightness—Docetaxel—head and neck cancer	0.00135	0.0118	CcSEcCtD
Pentamidine—Interstitial pneumonia—Docetaxel—head and neck cancer	0.00131	0.0114	CcSEcCtD
Pentamidine—Creatinine increased—Hydroxyurea—head and neck cancer	0.00128	0.0112	CcSEcCtD
Pentamidine—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00116	0.0101	CcSEcCtD
Pentamidine—Blood urea increased—Hydroxyurea—head and neck cancer	0.00115	0.01	CcSEcCtD
Pentamidine—Phlebitis—Vinblastine—head and neck cancer	0.00112	0.00982	CcSEcCtD
Pentamidine—Necrosis—Fluorouracil—head and neck cancer	0.00112	0.00975	CcSEcCtD
Pentamidine—Extravasation—Fluorouracil—head and neck cancer	0.001	0.00877	CcSEcCtD
Pentamidine—Oral candidiasis—Docetaxel—head and neck cancer	0.000996	0.00869	CcSEcCtD
Pentamidine—Cerebrovascular accident—Vinblastine—head and neck cancer	0.000989	0.00863	CcSEcCtD
Pentamidine—Renal failure acute—Hydroxyurea—head and neck cancer	0.000957	0.00836	CcSEcCtD
Pentamidine—Neuralgia—Docetaxel—head and neck cancer	0.00091	0.00795	CcSEcCtD
Pentamidine—Interstitial lung disease—Docetaxel—head and neck cancer	0.000894	0.0078	CcSEcCtD
Pentamidine—Face oedema—Hydroxyurea—head and neck cancer	0.000853	0.00745	CcSEcCtD
Pentamidine—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.000828	0.00723	CcSEcCtD
Pentamidine—Necrosis—Docetaxel—head and neck cancer	0.000806	0.00703	CcSEcCtD
Pentamidine—Pancytopenia—Vinblastine—head and neck cancer	0.000795	0.00694	CcSEcCtD
Pentamidine—Ageusia—Docetaxel—head and neck cancer	0.000781	0.00682	CcSEcCtD
Pentamidine—Sepsis—Fluorouracil—head and neck cancer	0.000761	0.00664	CcSEcCtD
Pentamidine—Pancreatitis—Hydroxyurea—head and neck cancer	0.000749	0.00654	CcSEcCtD
Pentamidine—Neuropathy peripheral—Vinblastine—head and neck cancer	0.000732	0.00639	CcSEcCtD
Pentamidine—Pancytopenia—Hydroxyurea—head and neck cancer	0.000725	0.00633	CcSEcCtD
Pentamidine—Extravasation—Docetaxel—head and neck cancer	0.000725	0.00633	CcSEcCtD
Pentamidine—Chest discomfort—Docetaxel—head and neck cancer	0.000715	0.00624	CcSEcCtD
Pentamidine—Neutropenia—Hydroxyurea—head and neck cancer	0.000714	0.00623	CcSEcCtD
Pentamidine—Drowsiness—Hydroxyurea—head and neck cancer	0.000681	0.00595	CcSEcCtD
Pentamidine—Amnesia—Fluorouracil—head and neck cancer	0.000677	0.00591	CcSEcCtD
Pentamidine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	0.000668	0.00583	CcSEcCtD
Pentamidine—Hypoaesthesia—Vinblastine—head and neck cancer	0.000667	0.00582	CcSEcCtD
Pentamidine—Pharyngitis—Vinblastine—head and neck cancer	0.000665	0.00581	CcSEcCtD
Pentamidine—Stomatitis—Hydroxyurea—head and neck cancer	0.000664	0.0058	CcSEcCtD
Pentamidine—Lethargy—Fluorouracil—head and neck cancer	0.000649	0.00567	CcSEcCtD
Pentamidine—Hallucination—Hydroxyurea—head and neck cancer	0.000608	0.00531	CcSEcCtD
Pentamidine—Colitis—Docetaxel—head and neck cancer	0.000607	0.0053	CcSEcCtD
Pentamidine—Skin exfoliation—Docetaxel—head and neck cancer	0.000604	0.00527	CcSEcCtD
Pentamidine—Candida infection—Docetaxel—head and neck cancer	0.000604	0.00527	CcSEcCtD
Pentamidine—Neuropathy—Docetaxel—head and neck cancer	0.000594	0.00518	CcSEcCtD
Pentamidine—Dry skin—Fluorouracil—head and neck cancer	0.000583	0.00509	CcSEcCtD
Pentamidine—Lightheadedness—Docetaxel—head and neck cancer	0.000566	0.00494	CcSEcCtD
Pentamidine—Sepsis—Docetaxel—head and neck cancer	0.000549	0.00479	CcSEcCtD
Pentamidine—Chills—Hydroxyurea—head and neck cancer	0.000549	0.00479	CcSEcCtD
Pentamidine—Eosinophilia—Fluorouracil—head and neck cancer	0.000544	0.00475	CcSEcCtD
Pentamidine—Anaemia—Vinblastine—head and neck cancer	0.000539	0.00471	CcSEcCtD
Pentamidine—Phlebitis—Docetaxel—head and neck cancer	0.000533	0.00465	CcSEcCtD
Pentamidine—Erythema—Hydroxyurea—head and neck cancer	0.000532	0.00465	CcSEcCtD
Pentamidine—Vertigo—Vinblastine—head and neck cancer	0.000524	0.00458	CcSEcCtD
Pentamidine—Leukopenia—Vinblastine—head and neck cancer	0.000522	0.00456	CcSEcCtD
Pentamidine—Pancytopenia—Fluorouracil—head and neck cancer	0.000522	0.00456	CcSEcCtD
Pentamidine—Convulsion—Vinblastine—head and neck cancer	0.000506	0.00441	CcSEcCtD
Pentamidine—Hypertension—Vinblastine—head and neck cancer	0.000504	0.0044	CcSEcCtD
Pentamidine—Anaemia—Hydroxyurea—head and neck cancer	0.000492	0.00429	CcSEcCtD
Pentamidine—Discomfort—Vinblastine—head and neck cancer	0.000491	0.00429	CcSEcCtD
Pentamidine—Renal impairment—Docetaxel—head and neck cancer	0.000482	0.00421	CcSEcCtD
Pentamidine—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000481	0.00419	CcSEcCtD
Pentamidine—Stomatitis—Fluorouracil—head and neck cancer	0.000478	0.00417	CcSEcCtD
Pentamidine—Conjunctivitis—Fluorouracil—head and neck cancer	0.000477	0.00416	CcSEcCtD
Pentamidine—Leukopenia—Hydroxyurea—head and neck cancer	0.000476	0.00416	CcSEcCtD
Pentamidine—Lethargy—Docetaxel—head and neck cancer	0.000469	0.00409	CcSEcCtD
Pentamidine—Thrombocytopenia—Vinblastine—head and neck cancer	0.000466	0.00407	CcSEcCtD
Pentamidine—Convulsion—Hydroxyurea—head and neck cancer	0.000461	0.00403	CcSEcCtD
Pentamidine—Sinusitis—Fluorouracil—head and neck cancer	0.00046	0.00401	CcSEcCtD
Pentamidine—Anorexia—Vinblastine—head and neck cancer	0.000454	0.00396	CcSEcCtD
Pentamidine—Discomfort—Hydroxyurea—head and neck cancer	0.000448	0.00391	CcSEcCtD
Pentamidine—Rhinitis—Fluorouracil—head and neck cancer	0.000441	0.00385	CcSEcCtD
Pentamidine—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000438	0.00382	CcSEcCtD
Pentamidine—Pharyngitis—Fluorouracil—head and neck cancer	0.000437	0.00381	CcSEcCtD
Pentamidine—Infection—Hydroxyurea—head and neck cancer	0.000432	0.00377	CcSEcCtD
Pentamidine—Paraesthesia—Vinblastine—head and neck cancer	0.000428	0.00373	CcSEcCtD
Pentamidine—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000425	0.00371	CcSEcCtD
Pentamidine—Liver function test abnormal—Docetaxel—head and neck cancer	0.000424	0.0037	CcSEcCtD
Pentamidine—Dry skin—Docetaxel—head and neck cancer	0.000421	0.00367	CcSEcCtD
Pentamidine—Anorexia—Hydroxyurea—head and neck cancer	0.000414	0.00361	CcSEcCtD
Pentamidine—Decreased appetite—Vinblastine—head and neck cancer	0.000414	0.00361	CcSEcCtD
Pentamidine—Pain—Vinblastine—head and neck cancer	0.000407	0.00356	CcSEcCtD
Pentamidine—Constipation—Vinblastine—head and neck cancer	0.000407	0.00356	CcSEcCtD
Pentamidine—Arrhythmia—Fluorouracil—head and neck cancer	0.000393	0.00343	CcSEcCtD
Pentamidine—Feeling abnormal—Vinblastine—head and neck cancer	0.000393	0.00343	CcSEcCtD
Pentamidine—Bronchospasm—Docetaxel—head and neck cancer	0.00039	0.00341	CcSEcCtD
Pentamidine—Gastrointestinal pain—Vinblastine—head and neck cancer	0.00039	0.0034	CcSEcCtD
Pentamidine—Dyspnoea—Hydroxyurea—head and neck cancer	0.000387	0.00338	CcSEcCtD
Pentamidine—Somnolence—Hydroxyurea—head and neck cancer	0.000386	0.00337	CcSEcCtD
Pentamidine—Erythema—Fluorouracil—head and neck cancer	0.000383	0.00334	CcSEcCtD
Pentamidine—Dyspepsia—Hydroxyurea—head and neck cancer	0.000382	0.00334	CcSEcCtD
Pentamidine—Decreased appetite—Hydroxyurea—head and neck cancer	0.000378	0.0033	CcSEcCtD
Pentamidine—Pancytopenia—Docetaxel—head and neck cancer	0.000377	0.00329	CcSEcCtD
Pentamidine—Abdominal pain—Vinblastine—head and neck cancer	0.000377	0.00329	CcSEcCtD
Pentamidine—Fatigue—Hydroxyurea—head and neck cancer	0.000375	0.00327	CcSEcCtD
Pentamidine—Pain—Hydroxyurea—head and neck cancer	0.000371	0.00324	CcSEcCtD
Pentamidine—Constipation—Hydroxyurea—head and neck cancer	0.000371	0.00324	CcSEcCtD
Pentamidine—Neutropenia—Docetaxel—head and neck cancer	0.000371	0.00324	CcSEcCtD
Pentamidine—Vision blurred—Fluorouracil—head and neck cancer	0.000361	0.00315	CcSEcCtD
Pentamidine—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000358	0.00312	CcSEcCtD
Pentamidine—Anaemia—Fluorouracil—head and neck cancer	0.000354	0.00309	CcSEcCtD
Pentamidine—Hypersensitivity—Vinblastine—head and neck cancer	0.000351	0.00306	CcSEcCtD
Pentamidine—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000351	0.00306	CcSEcCtD
Pentamidine—Renal failure—Docetaxel—head and neck cancer	0.000348	0.00304	CcSEcCtD
Pentamidine—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000347	0.00303	CcSEcCtD
Pentamidine—Stomatitis—Docetaxel—head and neck cancer	0.000345	0.00301	CcSEcCtD
Pentamidine—Conjunctivitis—Docetaxel—head and neck cancer	0.000344	0.003	CcSEcCtD
Pentamidine—Body temperature increased—Hydroxyurea—head and neck cancer	0.000343	0.003	CcSEcCtD
Pentamidine—Leukopenia—Fluorouracil—head and neck cancer	0.000343	0.00299	CcSEcCtD
Pentamidine—Asthenia—Vinblastine—head and neck cancer	0.000342	0.00298	CcSEcCtD
Pentamidine—Convulsion—Fluorouracil—head and neck cancer	0.000332	0.0029	CcSEcCtD
Pentamidine—Myalgia—Fluorouracil—head and neck cancer	0.000326	0.00285	CcSEcCtD
Pentamidine—Chest pain—Fluorouracil—head and neck cancer	0.000326	0.00285	CcSEcCtD
Pentamidine—Diarrhoea—Vinblastine—head and neck cancer	0.000326	0.00284	CcSEcCtD
Pentamidine—Discomfort—Fluorouracil—head and neck cancer	0.000322	0.00281	CcSEcCtD
Pentamidine—Hypersensitivity—Hydroxyurea—head and neck cancer	0.00032	0.00279	CcSEcCtD
Pentamidine—Rhinitis—Docetaxel—head and neck cancer	0.000318	0.00278	CcSEcCtD
Pentamidine—Hepatitis—Docetaxel—head and neck cancer	0.000318	0.00277	CcSEcCtD
Pentamidine—Hypoaesthesia—Docetaxel—head and neck cancer	0.000316	0.00276	CcSEcCtD
Pentamidine—Confusional state—Fluorouracil—head and neck cancer	0.000315	0.00275	CcSEcCtD
Pentamidine—Pharyngitis—Docetaxel—head and neck cancer	0.000315	0.00275	CcSEcCtD
Pentamidine—Dizziness—Vinblastine—head and neck cancer	0.000315	0.00275	CcSEcCtD
Pentamidine—Oedema peripheral—Docetaxel—head and neck cancer	0.000313	0.00273	CcSEcCtD
Pentamidine—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000313	0.00273	CcSEcCtD
Pentamidine—Asthenia—Hydroxyurea—head and neck cancer	0.000312	0.00272	CcSEcCtD
Pentamidine—Infection—Fluorouracil—head and neck cancer	0.000311	0.00271	CcSEcCtD
Pentamidine—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000306	0.00267	CcSEcCtD
Pentamidine—Tachycardia—Fluorouracil—head and neck cancer	0.000305	0.00266	CcSEcCtD
Pentamidine—Vomiting—Vinblastine—head and neck cancer	0.000303	0.00264	CcSEcCtD
Pentamidine—Erythema multiforme—Docetaxel—head and neck cancer	0.0003	0.00262	CcSEcCtD
Pentamidine—Headache—Vinblastine—head and neck cancer	0.000298	0.0026	CcSEcCtD
Pentamidine—Anorexia—Fluorouracil—head and neck cancer	0.000298	0.0026	CcSEcCtD
Pentamidine—Diarrhoea—Hydroxyurea—head and neck cancer	0.000297	0.00259	CcSEcCtD
Pentamidine—Flushing—Docetaxel—head and neck cancer	0.000295	0.00257	CcSEcCtD
Pentamidine—Hypotension—Fluorouracil—head and neck cancer	0.000292	0.00255	CcSEcCtD
Pentamidine—Dizziness—Hydroxyurea—head and neck cancer	0.000287	0.00251	CcSEcCtD
Pentamidine—Chills—Docetaxel—head and neck cancer	0.000285	0.00249	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000285	0.00249	CcSEcCtD
Pentamidine—Arrhythmia—Docetaxel—head and neck cancer	0.000284	0.00248	CcSEcCtD
Pentamidine—Nausea—Vinblastine—head and neck cancer	0.000283	0.00247	CcSEcCtD
Pentamidine—Insomnia—Fluorouracil—head and neck cancer	0.000283	0.00247	CcSEcCtD
Pentamidine—Paraesthesia—Fluorouracil—head and neck cancer	0.000281	0.00245	CcSEcCtD
Pentamidine—Dyspnoea—Fluorouracil—head and neck cancer	0.000279	0.00243	CcSEcCtD
Pentamidine—Somnolence—Fluorouracil—head and neck cancer	0.000278	0.00243	CcSEcCtD
Pentamidine—Erythema—Docetaxel—head and neck cancer	0.000277	0.00241	CcSEcCtD
Pentamidine—Vomiting—Hydroxyurea—head and neck cancer	0.000276	0.00241	CcSEcCtD
Pentamidine—Dyspepsia—Fluorouracil—head and neck cancer	0.000275	0.0024	CcSEcCtD
Pentamidine—Rash—Hydroxyurea—head and neck cancer	0.000274	0.00239	CcSEcCtD
Pentamidine—Dermatitis—Hydroxyurea—head and neck cancer	0.000274	0.00239	CcSEcCtD
Pentamidine—Headache—Hydroxyurea—head and neck cancer	0.000272	0.00238	CcSEcCtD
Pentamidine—Decreased appetite—Fluorouracil—head and neck cancer	0.000272	0.00237	CcSEcCtD
Pentamidine—Dysgeusia—Docetaxel—head and neck cancer	0.000271	0.00236	CcSEcCtD
Pentamidine—Pain—Fluorouracil—head and neck cancer	0.000267	0.00233	CcSEcCtD
Pentamidine—Nausea—Hydroxyurea—head and neck cancer	0.000258	0.00225	CcSEcCtD
Pentamidine—Feeling abnormal—Fluorouracil—head and neck cancer	0.000258	0.00225	CcSEcCtD
Pentamidine—Anaemia—Docetaxel—head and neck cancer	0.000256	0.00223	CcSEcCtD
Pentamidine—Urticaria—Fluorouracil—head and neck cancer	0.000248	0.00217	CcSEcCtD
Pentamidine—Syncope—Docetaxel—head and neck cancer	0.000248	0.00216	CcSEcCtD
Pentamidine—Leukopenia—Docetaxel—head and neck cancer	0.000248	0.00216	CcSEcCtD
Pentamidine—Body temperature increased—Fluorouracil—head and neck cancer	0.000247	0.00216	CcSEcCtD
Pentamidine—Palpitations—Docetaxel—head and neck cancer	0.000244	0.00213	CcSEcCtD
Pentamidine—Loss of consciousness—Docetaxel—head and neck cancer	0.000243	0.00212	CcSEcCtD
Pentamidine—Cough—Docetaxel—head and neck cancer	0.000241	0.00211	CcSEcCtD
Pentamidine—Convulsion—Docetaxel—head and neck cancer	0.00024	0.00209	CcSEcCtD
Pentamidine—Hypertension—Docetaxel—head and neck cancer	0.000239	0.00208	CcSEcCtD
Pentamidine—Chest pain—Docetaxel—head and neck cancer	0.000235	0.00205	CcSEcCtD
Pentamidine—Myalgia—Docetaxel—head and neck cancer	0.000235	0.00205	CcSEcCtD
Pentamidine—Arthralgia—Docetaxel—head and neck cancer	0.000235	0.00205	CcSEcCtD
Pentamidine—Hypersensitivity—Fluorouracil—head and neck cancer	0.00023	0.00201	CcSEcCtD
Pentamidine—Dry mouth—Docetaxel—head and neck cancer	0.00023	0.00201	CcSEcCtD
Pentamidine—Confusional state—Docetaxel—head and neck cancer	0.000228	0.00199	CcSEcCtD
Pentamidine—Anaphylactic shock—Docetaxel—head and neck cancer	0.000226	0.00197	CcSEcCtD
Pentamidine—Infection—Docetaxel—head and neck cancer	0.000224	0.00196	CcSEcCtD
Pentamidine—Shock—Docetaxel—head and neck cancer	0.000222	0.00194	CcSEcCtD
Pentamidine—Pruritus—Fluorouracil—head and neck cancer	0.000221	0.00193	CcSEcCtD
Pentamidine—Thrombocytopenia—Docetaxel—head and neck cancer	0.000221	0.00193	CcSEcCtD
Pentamidine—Tachycardia—Docetaxel—head and neck cancer	0.00022	0.00192	CcSEcCtD
Pentamidine—Anorexia—Docetaxel—head and neck cancer	0.000215	0.00188	CcSEcCtD
Pentamidine—Diarrhoea—Fluorouracil—head and neck cancer	0.000214	0.00187	CcSEcCtD
Pentamidine—Hypotension—Docetaxel—head and neck cancer	0.000211	0.00184	CcSEcCtD
Pentamidine—Dizziness—Fluorouracil—head and neck cancer	0.000207	0.0018	CcSEcCtD
Pentamidine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000206	0.00179	CcSEcCtD
Pentamidine—Insomnia—Docetaxel—head and neck cancer	0.000204	0.00178	CcSEcCtD
Pentamidine—Paraesthesia—Docetaxel—head and neck cancer	0.000203	0.00177	CcSEcCtD
Pentamidine—Dyspnoea—Docetaxel—head and neck cancer	0.000201	0.00176	CcSEcCtD
Pentamidine—Somnolence—Docetaxel—head and neck cancer	0.000201	0.00175	CcSEcCtD
Pentamidine—Vomiting—Fluorouracil—head and neck cancer	0.000199	0.00174	CcSEcCtD
Pentamidine—Dyspepsia—Docetaxel—head and neck cancer	0.000199	0.00173	CcSEcCtD
Pentamidine—Rash—Fluorouracil—head and neck cancer	0.000197	0.00172	CcSEcCtD
Pentamidine—Dermatitis—Fluorouracil—head and neck cancer	0.000197	0.00172	CcSEcCtD
Pentamidine—Decreased appetite—Docetaxel—head and neck cancer	0.000196	0.00171	CcSEcCtD
Pentamidine—Headache—Fluorouracil—head and neck cancer	0.000196	0.00171	CcSEcCtD
Pentamidine—Fatigue—Docetaxel—head and neck cancer	0.000195	0.0017	CcSEcCtD
Pentamidine—Pain—Docetaxel—head and neck cancer	0.000193	0.00168	CcSEcCtD
Pentamidine—Constipation—Docetaxel—head and neck cancer	0.000193	0.00168	CcSEcCtD
Pentamidine—CYP2C19—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000189	0.00279	CbGpPWpGaD
Pentamidine—Feeling abnormal—Docetaxel—head and neck cancer	0.000186	0.00162	CcSEcCtD
Pentamidine—Nausea—Fluorouracil—head and neck cancer	0.000186	0.00162	CcSEcCtD
Pentamidine—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000185	0.00161	CcSEcCtD
Pentamidine—CYP1A1—Biological oxidations—NAT2—head and neck cancer	0.000183	0.00271	CbGpPWpGaD
Pentamidine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000183	0.0027	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—MAPK1—head and neck cancer	0.000181	0.00268	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—EGFR—head and neck cancer	0.000181	0.00268	CbGpPWpGaD
Pentamidine—CYP1A1—Metapathway biotransformation—NAT2—head and neck cancer	0.000181	0.00267	CbGpPWpGaD
Pentamidine—CYP2C8—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.00018	0.00267	CbGpPWpGaD
Pentamidine—Abdominal pain—Docetaxel—head and neck cancer	0.000178	0.00156	CcSEcCtD
Pentamidine—Body temperature increased—Docetaxel—head and neck cancer	0.000178	0.00156	CcSEcCtD
Pentamidine—S100B—Immune System—STAT6—head and neck cancer	0.000173	0.00256	CbGpPWpGaD
Pentamidine—CYP3A5—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000171	0.00253	CbGpPWpGaD
Pentamidine—CYP2C8—Biological oxidations—NAT2—head and neck cancer	0.000168	0.00249	CbGpPWpGaD
Pentamidine—Hypersensitivity—Docetaxel—head and neck cancer	0.000166	0.00145	CcSEcCtD
Pentamidine—CYP2C8—Metapathway biotransformation—NAT2—head and neck cancer	0.000166	0.00245	CbGpPWpGaD
Pentamidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000163	0.00241	CbGpPWpGaD
Pentamidine—Asthenia—Docetaxel—head and neck cancer	0.000162	0.00141	CcSEcCtD
Pentamidine—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000161	0.00238	CbGpPWpGaD
Pentamidine—Pruritus—Docetaxel—head and neck cancer	0.00016	0.00139	CcSEcCtD
Pentamidine—S100B—Signaling by ERBB4—PIK3CA—head and neck cancer	0.000157	0.00233	CbGpPWpGaD
Pentamidine—CYP1A2—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000157	0.00233	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1A1—head and neck cancer	0.000157	0.00233	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1A1—head and neck cancer	0.000157	0.00233	CbGpPWpGaD
Pentamidine—Diarrhoea—Docetaxel—head and neck cancer	0.000154	0.00135	CcSEcCtD
Pentamidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00015	0.00222	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—NAT2—head and neck cancer	0.00015	0.00222	CbGpPWpGaD
Pentamidine—Dizziness—Docetaxel—head and neck cancer	0.000149	0.0013	CcSEcCtD
Pentamidine—CYP1A2—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000148	0.0022	CbGpPWpGaD
Pentamidine—CYP2C8—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000148	0.00219	CbGpPWpGaD
Pentamidine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000148	0.00219	CbGpPWpGaD
Pentamidine—CYP2C19—Metapathway biotransformation—NAT2—head and neck cancer	0.000148	0.00219	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000148	0.00218	CbGpPWpGaD
Pentamidine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—YAP1—head and neck cancer	0.000147	0.00218	CbGpPWpGaD
Pentamidine—CYP1A2—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000147	0.00218	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	0.000147	0.00217	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—HRAS—head and neck cancer	0.000145	0.00215	CbGpPWpGaD
Pentamidine—Vomiting—Docetaxel—head and neck cancer	0.000143	0.00125	CcSEcCtD
Pentamidine—Rash—Docetaxel—head and neck cancer	0.000142	0.00124	CcSEcCtD
Pentamidine—Dermatitis—Docetaxel—head and neck cancer	0.000142	0.00124	CcSEcCtD
Pentamidine—Headache—Docetaxel—head and neck cancer	0.000141	0.00123	CcSEcCtD
Pentamidine—S100B—Signaling Pathways—KISS1—head and neck cancer	0.00014	0.00207	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—NAT2—head and neck cancer	0.000138	0.00204	CbGpPWpGaD
Pentamidine—CYP1A1—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000137	0.00203	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—NAT2—head and neck cancer	0.000136	0.00201	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	0.000136	0.00201	CbGpPWpGaD
Pentamidine—Nausea—Docetaxel—head and neck cancer	0.000134	0.00117	CcSEcCtD
Pentamidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000132	0.00196	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—BCL2L1—head and neck cancer	0.000132	0.00195	CbGpPWpGaD
Pentamidine—S100B—Signaling by ERBB4—AKT1—head and neck cancer	0.000128	0.0019	CbGpPWpGaD
Pentamidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.000127	0.00188	CbGpPWpGaD
Pentamidine—CYP2C8—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000126	0.00186	CbGpPWpGaD
Pentamidine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000125	0.00186	CbGpPWpGaD
Pentamidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000122	0.0018	CbGpPWpGaD
Pentamidine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	0.000121	0.00179	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—NAT2—head and neck cancer	0.000117	0.00173	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000115	0.00171	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—NAT2—head and neck cancer	0.000115	0.00171	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—GRP—head and neck cancer	0.000115	0.0017	CbGpPWpGaD
Pentamidine—CYP2C19—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000112	0.00166	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—STAT6—head and neck cancer	0.000112	0.00165	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—CASP8—head and neck cancer	0.000108	0.0016	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000104	0.00154	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000104	0.00154	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	0.000104	0.00154	CbGpPWpGaD
Pentamidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000103	0.00152	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—YAP1—head and neck cancer	9.89e-05	0.00146	CbGpPWpGaD
Pentamidine—CYP1A2—Phase II conjugation—GSTM1—head and neck cancer	9.86e-05	0.00146	CbGpPWpGaD
Pentamidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	9.8e-05	0.00145	CbGpPWpGaD
Pentamidine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	9.67e-05	0.00143	CbGpPWpGaD
Pentamidine—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	9.58e-05	0.00142	CbGpPWpGaD
Pentamidine—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	9.45e-05	0.0014	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—head and neck cancer	9.34e-05	0.00138	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—BCL2—head and neck cancer	9.25e-05	0.00137	CbGpPWpGaD
Pentamidine—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	9.08e-05	0.00134	CbGpPWpGaD
Pentamidine—CYP1A1—Biological oxidations—GSTM1—head and neck cancer	9.05e-05	0.00134	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	9.02e-05	0.00133	CbGpPWpGaD
Pentamidine—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	8.96e-05	0.00133	CbGpPWpGaD
Pentamidine—CYP1A1—Metapathway biotransformation—GSTM1—head and neck cancer	8.93e-05	0.00132	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	8.89e-05	0.00132	CbGpPWpGaD
Pentamidine—CYP1A2—Arachidonic acid metabolism—PTGS2—head and neck cancer	8.74e-05	0.00129	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—head and neck cancer	8.66e-05	0.00128	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	8.39e-05	0.00124	CbGpPWpGaD
Pentamidine—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	8.34e-05	0.00123	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	8.3e-05	0.00123	CbGpPWpGaD
Pentamidine—CYP2C8—Biological oxidations—GSTM1—head and neck cancer	8.3e-05	0.00123	CbGpPWpGaD
Pentamidine—CYP2C8—Metapathway biotransformation—GSTM1—head and neck cancer	8.18e-05	0.00121	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—UROD—head and neck cancer	7.99e-05	0.00118	CbGpPWpGaD
Pentamidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	7.95e-05	0.00118	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—NAT2—head and neck cancer	7.9e-05	0.00117	CbGpPWpGaD
Pentamidine—CYP2C8—Biological oxidations—CYP1A1—head and neck cancer	7.87e-05	0.00116	CbGpPWpGaD
Pentamidine—CYP2C8—Metapathway biotransformation—CYP1A1—head and neck cancer	7.76e-05	0.00115	CbGpPWpGaD
Pentamidine—S100B—Immune System—BCL2L1—head and neck cancer	7.68e-05	0.00114	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—PTEN—head and neck cancer	7.66e-05	0.00113	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—UROD—head and neck cancer	7.55e-05	0.00112	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—GSTM1—head and neck cancer	7.41e-05	0.0011	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	7.36e-05	0.00109	CbGpPWpGaD
Pentamidine—CYP2C19—Metapathway biotransformation—GSTM1—head and neck cancer	7.3e-05	0.00108	CbGpPWpGaD
Pentamidine—CYP2C19—Biological oxidations—CYP1A1—head and neck cancer	7.02e-05	0.00104	CbGpPWpGaD
Pentamidine—CYP2C19—Metapathway biotransformation—CYP1A1—head and neck cancer	6.92e-05	0.00102	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—DPYD—head and neck cancer	6.92e-05	0.00102	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—UROD—head and neck cancer	6.92e-05	0.00102	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—GSTM1—head and neck cancer	6.81e-05	0.00101	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—GSTM1—head and neck cancer	6.72e-05	0.000994	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	6.62e-05	0.000981	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—head and neck cancer	6.62e-05	0.00098	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	6.62e-05	0.00098	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—YAP1—head and neck cancer	6.57e-05	0.000973	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—MAPK3—head and neck cancer	6.55e-05	0.000969	CbGpPWpGaD
Pentamidine—CYP2D6—Biological oxidations—CYP1A1—head and neck cancer	6.46e-05	0.000956	CbGpPWpGaD
Pentamidine—CYP2D6—Metapathway biotransformation—CYP1A1—head and neck cancer	6.37e-05	0.000943	CbGpPWpGaD
Pentamidine—S100B—Immune System—CASP8—head and neck cancer	6.28e-05	0.000929	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—MAPK1—head and neck cancer	6.23e-05	0.000922	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—EGFR—head and neck cancer	6.23e-05	0.000922	CbGpPWpGaD
Pentamidine—S100B—Immune System—CDH1—head and neck cancer	6.2e-05	0.000918	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—UROD—head and neck cancer	6.18e-05	0.000914	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.85e-05	0.000867	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—GSTM1—head and neck cancer	5.77e-05	0.000854	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—GSTM1—head and neck cancer	5.69e-05	0.000842	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—UROD—head and neck cancer	5.68e-05	0.000841	CbGpPWpGaD
Pentamidine—CYP1A2—Biological oxidations—CYP1A1—head and neck cancer	5.47e-05	0.00081	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—PIK3CA—head and neck cancer	5.41e-05	0.0008	CbGpPWpGaD
Pentamidine—CYP1A2—Metapathway biotransformation—CYP1A1—head and neck cancer	5.39e-05	0.000799	CbGpPWpGaD
Pentamidine—S100B—Immune System—BCL2—head and neck cancer	5.39e-05	0.000798	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	5.37e-05	0.000795	CbGpPWpGaD
Pentamidine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	5.32e-05	0.000787	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—HRAS—head and neck cancer	5e-05	0.00074	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.94e-05	0.000731	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—UROD—head and neck cancer	4.81e-05	0.000712	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	4.79e-05	0.000709	CbGpPWpGaD
Pentamidine—S100B—Immune System—IL2—head and neck cancer	4.74e-05	0.000702	CbGpPWpGaD
Pentamidine—S100B—Immune System—PTEN—head and neck cancer	4.46e-05	0.000661	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—NOTCH1—head and neck cancer	4.46e-05	0.00066	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	4.45e-05	0.000659	CbGpPWpGaD
Pentamidine—S100B—Innate Immune System—AKT1—head and neck cancer	4.42e-05	0.000654	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	4.39e-05	0.00065	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.31e-05	0.000637	CbGpPWpGaD
Pentamidine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	4.22e-05	0.000625	CbGpPWpGaD
Pentamidine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	4.16e-05	0.000616	CbGpPWpGaD
Pentamidine—S100B—Immune System—STAT3—head and neck cancer	3.99e-05	0.000591	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—TYMS—head and neck cancer	3.95e-05	0.000584	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—GSTM1—head and neck cancer	3.9e-05	0.000577	CbGpPWpGaD
Pentamidine—S100B—Immune System—MAPK3—head and neck cancer	3.81e-05	0.000565	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—GPX1—head and neck cancer	3.73e-05	0.000553	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	3.73e-05	0.000553	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—UROD—head and neck cancer	3.71e-05	0.00055	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—CYP1A1—head and neck cancer	3.7e-05	0.000547	CbGpPWpGaD
Pentamidine—S100B—Immune System—MAPK1—head and neck cancer	3.63e-05	0.000537	CbGpPWpGaD
Pentamidine—S100B—Immune System—EGFR—head and neck cancer	3.63e-05	0.000537	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.33e-05	0.000493	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—NAT2—head and neck cancer	3.32e-05	0.000491	CbGpPWpGaD
Pentamidine—S100B—Immune System—PIK3CA—head and neck cancer	3.15e-05	0.000466	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—NAT2—head and neck cancer	3.13e-05	0.000464	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—IL2—head and neck cancer	3.07e-05	0.000454	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.05e-05	0.000452	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.04e-05	0.00045	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.02e-05	0.000447	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—CCND1—head and neck cancer	2.99e-05	0.000443	CbGpPWpGaD
Pentamidine—S100B—Immune System—HRAS—head and neck cancer	2.91e-05	0.000431	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—DPYD—head and neck cancer	2.91e-05	0.00043	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PTEN—head and neck cancer	2.89e-05	0.000427	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—NAT2—head and neck cancer	2.87e-05	0.000425	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—YAP1—head and neck cancer	2.76e-05	0.000409	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—DPYD—head and neck cancer	2.75e-05	0.000407	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.72e-05	0.000403	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.7e-05	0.000399	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—YAP1—head and neck cancer	2.61e-05	0.000386	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—VEGFA—head and neck cancer	2.61e-05	0.000386	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—STAT3—head and neck cancer	2.58e-05	0.000382	CbGpPWpGaD
Pentamidine—S100B—Immune System—AKT1—head and neck cancer	2.57e-05	0.000381	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—NAT2—head and neck cancer	2.56e-05	0.00038	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—DPYD—head and neck cancer	2.52e-05	0.000373	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MAPK3—head and neck cancer	2.47e-05	0.000365	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—YAP1—head and neck cancer	2.39e-05	0.000354	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—NAT2—head and neck cancer	2.36e-05	0.000349	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—MAPK1—head and neck cancer	2.35e-05	0.000347	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—EGFR—head and neck cancer	2.35e-05	0.000347	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—DPYD—head and neck cancer	2.25e-05	0.000333	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTGS2—head and neck cancer	2.2e-05	0.000325	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—YAP1—head and neck cancer	2.13e-05	0.000316	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	2.12e-05	0.000314	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	2.1e-05	0.000311	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—DPYD—head and neck cancer	2.07e-05	0.000306	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—PIK3CA—head and neck cancer	2.04e-05	0.000301	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—NAT2—head and neck cancer	2e-05	0.000296	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—TP53—head and neck cancer	1.97e-05	0.000292	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—YAP1—head and neck cancer	1.96e-05	0.00029	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.96e-05	0.00029	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PTEN—head and neck cancer	1.92e-05	0.000284	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—HRAS—head and neck cancer	1.88e-05	0.000279	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.8e-05	0.000266	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—DPYD—head and neck cancer	1.75e-05	0.000259	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.71e-05	0.000253	CbGpPWpGaD
Pentamidine—S100B—Signaling Pathways—AKT1—head and neck cancer	1.66e-05	0.000246	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—YAP1—head and neck cancer	1.66e-05	0.000246	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—TYMS—head and neck cancer	1.66e-05	0.000245	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GSTM1—head and neck cancer	1.64e-05	0.000242	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.6e-05	0.000237	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—GPX1—head and neck cancer	1.57e-05	0.000232	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.57e-05	0.000232	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—TYMS—head and neck cancer	1.57e-05	0.000232	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—CYP1A1—head and neck cancer	1.55e-05	0.00023	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GSTM1—head and neck cancer	1.55e-05	0.000229	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—NAT2—head and neck cancer	1.54e-05	0.000228	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—GPX1—head and neck cancer	1.48e-05	0.000219	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—TYMS—head and neck cancer	1.44e-05	0.000212	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GSTM1—head and neck cancer	1.42e-05	0.00021	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.4e-05	0.000207	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—GPX1—head and neck cancer	1.36e-05	0.000201	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—PIK3CA—head and neck cancer	1.35e-05	0.0002	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—DPYD—head and neck cancer	1.35e-05	0.0002	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—CYP1A1—head and neck cancer	1.35e-05	0.000199	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—YAP1—head and neck cancer	1.28e-05	0.00019	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—TYMS—head and neck cancer	1.28e-05	0.00019	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GSTM1—head and neck cancer	1.27e-05	0.000187	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.25e-05	0.000185	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—GPX1—head and neck cancer	1.21e-05	0.00018	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.21e-05	0.000178	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—CYP1A1—head and neck cancer	1.2e-05	0.000178	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—TYMS—head and neck cancer	1.18e-05	0.000174	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GSTM1—head and neck cancer	1.16e-05	0.000172	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—GPX1—head and neck cancer	1.12e-05	0.000165	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.11e-05	0.000164	CbGpPWpGaD
Pentamidine—CYP4A11—Metabolism—AKT1—head and neck cancer	1.11e-05	0.000164	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.1e-05	0.000163	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.09e-05	0.000161	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—TYMS—head and neck cancer	9.98e-06	0.000148	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GSTM1—head and neck cancer	9.87e-06	0.000146	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.86e-06	0.000146	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—GPX1—head and neck cancer	9.45e-06	0.00014	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—CYP1A1—head and neck cancer	9.35e-06	0.000138	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTGS2—head and neck cancer	9.24e-06	0.000137	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTGS2—head and neck cancer	8.72e-06	0.000129	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PTEN—head and neck cancer	8.05e-06	0.000119	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTGS2—head and neck cancer	8e-06	0.000118	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—TYMS—head and neck cancer	7.7e-06	0.000114	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.69e-06	0.000114	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GSTM1—head and neck cancer	7.62e-06	0.000113	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PTEN—head and neck cancer	7.61e-06	0.000113	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—GPX1—head and neck cancer	7.29e-06	0.000108	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	7.22e-06	0.000107	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTGS2—head and neck cancer	7.14e-06	0.000106	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PTEN—head and neck cancer	6.98e-06	0.000103	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTGS2—head and neck cancer	6.57e-06	9.72e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PTEN—head and neck cancer	6.23e-06	9.22e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PTEN—head and neck cancer	5.73e-06	8.48e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	5.68e-06	8.41e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTGS2—head and neck cancer	5.56e-06	8.23e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—PIK3CA—head and neck cancer	5.37e-06	7.95e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—PIK3CA—head and neck cancer	4.92e-06	7.28e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PTEN—head and neck cancer	4.85e-06	7.18e-05	CbGpPWpGaD
Pentamidine—CYP3A5—Metabolism—AKT1—head and neck cancer	4.64e-06	6.87e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—PIK3CA—head and neck cancer	4.39e-06	6.5e-05	CbGpPWpGaD
Pentamidine—CYP1A1—Metabolism—AKT1—head and neck cancer	4.39e-06	6.49e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTGS2—head and neck cancer	4.29e-06	6.36e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—PIK3CA—head and neck cancer	4.04e-06	5.98e-05	CbGpPWpGaD
Pentamidine—CYP2C8—Metabolism—AKT1—head and neck cancer	4.02e-06	5.95e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PTEN—head and neck cancer	3.74e-06	5.54e-05	CbGpPWpGaD
Pentamidine—CYP2C19—Metabolism—AKT1—head and neck cancer	3.59e-06	5.31e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—PIK3CA—head and neck cancer	3.42e-06	5.07e-05	CbGpPWpGaD
Pentamidine—CYP2D6—Metabolism—AKT1—head and neck cancer	3.3e-06	4.89e-05	CbGpPWpGaD
Pentamidine—CYP1A2—Metabolism—AKT1—head and neck cancer	2.8e-06	4.14e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	2.64e-06	3.91e-05	CbGpPWpGaD
Pentamidine—CYP3A4—Metabolism—AKT1—head and neck cancer	2.16e-06	3.19e-05	CbGpPWpGaD
